{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:28:43Z","timestamp":1791815323416,"version":"4.3.4"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Evidence regarding differences in survival associated with the site of metastasis in triple-negative breast cancer (TNBC) remains limited. Our aim was to analyze the overall survival (OS), distant relapse free survival (DRFS), and survival since the diagnosis of the relapse (MS), according to the side of metastasis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>This was a retrospective study of TNBC patients with distant metastases at the Instituto Nacional de Enfermedades Neoplasicas (Lima, Peru) from 2000 to 2014. Prognostic factors were determined by multivariate Cox regression analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 309 patients were included. Regarding the type of metastasis, visceral metastasis accounted for 41% and the lung was the most frequent first site of metastasis (33.3%). With a median follow-up of 10.2 years, the 5-year DRFS and OS were 10% and 26%, respectively. N staging (N2-N3 vs. N0, HR = 1.49, 95%CI: 1.04\u20132.14), metastasis in visceral sites (vs. bone; HR = 1.55, 95%CI: 0.94\u20132.56), the central nervous system (vs. bone; HR = 1.88, 95% CI: 1.10\u20133.22), and multiple sites (vs. bone; HR = 2.55, 95%CI:1.53\u20134.25) were prognostic factors of OS whereas multiple metastasis (HR = 2.30, 95% CI: 1.42\u20133.72) was a predictor of MS. In terms of DRFS, there were no differences according to metastasis type or solid organ.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>TNBC patients with multiple metastasis and CNS metastasis have an increased risk of death compared to those with bone metastasis in terms of OS and MS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0293833","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T18:43:26Z","timestamp":1706813006000},"page":"e0293833","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2844-2374","authenticated-orcid":true,"given":"Luis","family":"Piedra-Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Chambergo-Michilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaida","family":"Morante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fairen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Jerves-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Luque-Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fresia","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduarda","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6014-8427","authenticated-orcid":true,"given":"Cesar","family":"Razuri-Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Smith","family":"Torres-Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Narvaez-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-3890","authenticated-orcid":true,"given":"Gabriel","family":"De la Cruz-Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhajaira","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"3","key":"pone.0293833.ref001","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0897190012442062","article-title":"Triple negative breast cancer: a brief review of its characteristics and treatment options.","volume":"25","author":"CL Griffiths","year":"2012","journal-title":"J Pharm Pract [Internet]."},{"issue":"2","key":"pone.0293833.ref002","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","article-title":"Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA","volume":"113","author":"MJ Lund","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"pone.0293833.ref003","first-page":"1","article-title":"Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities.","volume":"57","author":"SA Dass","year":"2021","journal-title":"Medicina (B Aires)."},{"issue":"3","key":"pone.0293833.ref004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5306\/wjco.v12.i3.164","article-title":"Overview of recent advances in metastatic triple negative breast cancer.","volume":"12","author":"D O\u2019Reilly","year":"2021","journal-title":"World J Clin Oncol"},{"issue":"2","key":"pone.0293833.ref005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-016-4059-6","article-title":"Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer","volume":"161","author":"X Li","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"pone.0293833.ref006","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/bjc.2015.127","article-title":"Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?","volume":"112","author":"DJA Lobbezoo","year":"2015","journal-title":"Br J Cancer [Internet]."},{"issue":"2","key":"pone.0293833.ref007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10585-015-9697-2","article-title":"Pattern of metastasis and outcome in patients with breast cancer","volume":"32","author":"L Gerratana","year":"2015","journal-title":"Clin Exp Metastasis [Internet]."},{"issue":"3","key":"pone.0293833.ref008","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10549-015-3341-3","article-title":"Impact of breast cancer subtypes and patterns of metastasis on outcome","volume":"150","author":"K Kast","year":"2015","journal-title":"Breast Cancer Res Treat [Internet]."},{"issue":"7","key":"pone.0293833.ref009","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","article-title":"Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer","volume":"25","author":"AE Giuliano","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"SUPPL. 6","key":"pone.0293833.ref010","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: Epidemiological considerations and recommendations.","volume":"23","author":"P. Boyle","year":"2012","journal-title":"Annals of Oncology"},{"issue":"12","key":"pone.0293833.ref011","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/cncr.25862","article-title":"Higher population-based incidence rates of triple-negative breast cancer among young African-American women","volume":"117","author":"KC Amirikia","year":"2011","journal-title":"Cancer [Internet]."},{"issue":"11","key":"pone.0293833.ref012","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000162288","article-title":"Clinicopathologic and Prognostic Characteristics of Triple-Negative Breast Cancer.","volume":"31","author":"XS Tian","year":"2008","journal-title":"Oncol Res Treat [Internet]."},{"issue":"7","key":"pone.0293833.ref013","first-page":"1380","article-title":"An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.","volume":"6","author":"J Zhang","year":"2013","journal-title":"Int J Clin Exp Pathol [Internet]."},{"issue":"5","key":"pone.0293833.ref014","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamasurg.2019.6032","article-title":"Evaluation of Triple-Negative Breast Cancer Early Detection via Mammography Screening and Outcomes in African American and White American Patients.","volume":"155","author":"Y Chen","year":"2020","journal-title":"JAMA Surg [Internet]."},{"key":"pone.0293833.ref015","first-page":"181","article-title":"Status of breast cancer in Latin American: Results of the breast cancer revealed initiative.","author":"N Ayala","year":"2023","journal-title":"Crit Rev Oncol Hematol [Internet]."},{"key":"pone.0293833.ref016","first-page":"13","article-title":"Barriers in Latin America for the management of locally advanced breast cancer","author":"JA Pinto","year":"2019","journal-title":"Ecancermedicalscience [Internet]."},{"issue":"7","key":"pone.0293833.ref017","doi-asserted-by":"crossref","first-page":"797","DOI":"10.6004\/jnccn.2020.7659","article-title":"Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study.","volume":"19","author":"S Asad","year":"2021","journal-title":"J Natl Compr Canc Netw [Internet]."},{"issue":"1","key":"pone.0293833.ref018","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2559.2006.02453.x","article-title":"Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.","volume":"49","author":"LG Fulford","year":"2006","journal-title":"Histopathology [Internet]."},{"issue":"2","key":"pone.0293833.ref019","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/modpathol.3800528","article-title":"Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.","volume":"19","author":"CA Livasy","year":"2006","journal-title":"Mod Pathol [Internet]."},{"issue":"3","key":"pone.0293833.ref020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-015-3485-1","article-title":"Role of epithelial\u2013mesenchymal transition markers in triple-negative breast cancer","volume":"152","author":"SY Cheung","year":"2015","journal-title":"Breast Cancer Res Treat [Internet]."},{"issue":"5","key":"pone.0293833.ref021","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1524-4741.2009.00789.x","article-title":"T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy.","volume":"15","author":"HG Kaplan","year":"2009","journal-title":"Breast J [Internet]."},{"issue":"4","key":"pone.0293833.ref022","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing","volume":"173","author":"C Kim","year":"2018","journal-title":"Cell [Internet]."},{"key":"pone.0293833.ref023","first-page":"25","article-title":"Effects of adjuvant chemotherapy on recurrence rate in T1abN0M0 triple-negative breast cancer: A meta-analysis.","author":"Z Yang","year":"2020","journal-title":"Cancer Treat Res Commun [Internet]."},{"issue":"6","key":"pone.0293833.ref024","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.","volume":"20","author":"WJ Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw [Internet]."},{"issue":"15","key":"pone.0293833.ref025","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence","volume":"13","author":"R Dent","year":"2007","journal-title":"Clinical Cancer Research [Internet]."},{"issue":"5","key":"pone.0293833.ref026","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","article-title":"Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas","volume":"12","author":"SM Rodr\u00edguez-Pinilla","year":"2006","journal-title":"Clinical Cancer Research [Internet]."},{"issue":"2","key":"pone.0293833.ref027","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-008-0086-2","article-title":"Pattern of metastatic spread in triple-negative breast cancer","volume":"115","author":"R Dent","year":"2009","journal-title":"Breast Cancer Res Treat [Internet]."},{"issue":"1","key":"pone.0293833.ref028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12032-009-9166-3","article-title":"Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin.","volume":"27","author":"GG Dogu","year":"2010","journal-title":"Med Oncol [Internet]."},{"issue":"9","key":"pone.0293833.ref029","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/01.pas.0000213306.05811.b9","article-title":"Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5\/6, and overexpress HER2 or EGFR.","volume":"30","author":"DG Hicks","year":"2006","journal-title":"Am J Surg Pathol [Internet]."},{"issue":"9","key":"pone.0293833.ref030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5732\/cjc.011.10226","article-title":"Epithelial-mesenchymal transition in breast cancer progression and metastasis","volume":"30","author":"Y Wang","year":"2011","journal-title":"Chin J Cancer [Internet]."},{"issue":"1","key":"pone.0293833.ref031","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/modpathol.3880483","article-title":"Expression of cytokeratin 5\/6 in epithelial neoplasms: an immunohistochemical study of 509 cases.","volume":"15","author":"PG Chu","year":"2002","journal-title":"Mod Pathol [Internet]."},{"issue":"SUPPL. 7","key":"pone.0293833.ref032","doi-asserted-by":"crossref","first-page":"vii89","DOI":"10.1093\/annonc\/mdq292","article-title":"The epithelial-mesenchymal transition (EMT) phenomenon","volume":"21 Suppl 7","author":"P. Savagner","year":"2010","journal-title":"Annals of Oncology [Internet]."},{"issue":"10","key":"pone.0293833.ref033","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer","volume":"113","author":"NU Lin","year":"2008","journal-title":"Cancer [Internet]."},{"issue":"4","key":"pone.0293833.ref034","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1309\/AJCPYO5FSV3UPEXS","article-title":"Breast Cancer Subtypes Predispose the Site of Distant Metastases","volume":"143","author":"A Soni","year":"2015","journal-title":"Am J Clin Pathol [Internet]."},{"issue":"20","key":"pone.0293833.ref035","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"H Kennecke","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"pone.0293833.ref036","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00404-016-4225-4","article-title":"Pattern of metastatic spread and subcategories of breast cancer","volume":"295","author":"C Bartmann","year":"2017","journal-title":"Arch Gynecol Obstet [Internet]."},{"issue":"10","key":"pone.0293833.ref037","first-page":"858","article-title":"Breast cancer lung metastasis: Molecular biology and therapeutic implications.","volume":"19","author":"L Jin","year":"2018"},{"issue":"17","key":"pone.0293833.ref038","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study.","volume":"8","author":"Q Wu","year":"2017","journal-title":"Oncotarget [Internet]."},{"issue":"7050","key":"pone.0293833.ref039","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"AJ Minn","year":"2005","journal-title":"Nature [Internet]."},{"issue":"16","key":"pone.0293833.ref040","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1073\/pnas.0701138104","article-title":"Lung metastasis genes couple breast tumor size and metastatic spread","volume":"104","author":"AJ Minn","year":"2007","journal-title":"Proc Natl Acad Sci U S A [Internet]."},{"issue":"5","key":"pone.0293833.ref041","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/bcr2944","article-title":"Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study","volume":"13","author":"H Sihto","year":"2011","journal-title":"Breast Cancer Res [Internet]."},{"issue":"7137","key":"pone.0293833.ref042","first-page":"765","article-title":"Mediators of vascular remodelling co-opted for sequential steps in lung metastasis","volume":"446","author":"GP Gupta","year":"2007","journal-title":"Nature 2006 446:7137 [Internet]."},{"issue":"2","key":"pone.0293833.ref043","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0974-2727.163129","article-title":"Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas.","volume":"7","author":"AA Changavi","year":"2015","journal-title":"J Lab Physicians [Internet]."},{"issue":"1","key":"pone.0293833.ref044","doi-asserted-by":"crossref","first-page":"324","DOI":"10.7150\/jca.2.324","article-title":"Targeting EGFR in Triple Negative Breast Cancer.","volume":"2","author":"NT Ueno","year":"2011","journal-title":"J Cancer [Internet]."},{"issue":"12","key":"pone.0293833.ref045","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/annonc\/mdp492","article-title":"Triple-negative breast cancer\u2014current status and future directions","volume":"20","author":"O Gluz","year":"2009","journal-title":"Ann Oncol [Internet]."},{"issue":"9","key":"pone.0293833.ref046","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/jcp.2006.042143","article-title":"Vimentin and laminin expression is associated with basal\u2010like phenotype in both sporadic and BRCA1\u2010associated breast carcinomas","volume":"60","author":"SM Rodr\u00edguez-Pinilla","year":"2007","journal-title":"J Clin Pathol [Internet]."},{"issue":"4","key":"pone.0293833.ref047","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","article-title":"Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype","volume":"68","author":"D Sarri\u00f3","year":"2008","journal-title":"Cancer Res [Internet]."},{"issue":"3","key":"pone.0293833.ref048","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","article-title":"Triple-negative breast cancer: therapeutic options.","volume":"8","author":"S Cleator","year":"2007","journal-title":"Lancet Oncol [Internet]."},{"issue":"2","key":"pone.0293833.ref049","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","article-title":"Triple-negative breast cancer: promising prognostic biomarkers currently in development.","volume":"21","author":"J Sukumar","year":"2021","journal-title":"Expert Rev Anticancer Ther [Internet]."},{"issue":"5","key":"pone.0293833.ref050","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24816","article-title":"Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes","volume":"116","author":"MF Rimawi","year":"2010","journal-title":"Cancer [Internet]."},{"issue":"3","key":"pone.0293833.ref051","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00280-010-1548-x","article-title":"Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC).","volume":"68","author":"EY Cho","year":"2011","journal-title":"Cancer Chemother Pharmacol [Internet]."},{"issue":"2","key":"pone.0293833.ref052","first-page":"217","article-title":"Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.","volume":"50","author":"A Meche","year":"2009","journal-title":"Rom J Morphol Embryol [Internet]."},{"issue":"11","key":"pone.0293833.ref053","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.","volume":"13","author":"G Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol [Internet]."},{"issue":"8","key":"pone.0293833.ref054","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes","volume":"13","author":"LA Carey","year":"2007","journal-title":"Clinical Cancer Research [Internet]."},{"issue":"1","key":"pone.0293833.ref055","first-page":"40","article-title":"Triple-negative\/basal-like breast cancer: review.","volume":"41","author":"EA Rakha","year":"2009","journal-title":"Pathology [Internet]."},{"issue":"1","key":"pone.0293833.ref056","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-4741.2011.01175.x","article-title":"The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment.","volume":"18","author":"M Fornier","year":"2012","journal-title":"Breast J [Internet]."},{"issue":"15","key":"pone.0293833.ref057","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.20.01200","article-title":"Mutations in BRCA1\/2 and Other Panel Genes in Patients With Metastatic Breast Cancer\u2014Association With Patient and Disease Characteristics and Effect on Prognosis","volume":"39","author":"PA Fasching","year":"2021","journal-title":"Journal of Clinical Oncology [Internet]."},{"issue":"1","key":"pone.0293833.ref058","first-page":"108","article-title":"BRCA1 and Metastasis: Outcome of Defective DNA Repair.","volume":"14","author":"R Krishnan","year":"2021","journal-title":"Cancers 2022, Vol 14, Page 108 [Internet]."},{"issue":"2","key":"pone.0293833.ref059","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncr.32540","article-title":"Patterns of recurrence and metastasis in BRCA1\/BRCA2-associated breast cancers","volume":"126","author":"Y Song","year":"2020","journal-title":"Cancer [Internet]."},{"issue":"22","key":"pone.0293833.ref060","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1002\/cncr.27581","article-title":"Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network","volume":"118","author":"NU Lin","year":"2012","journal-title":"Cancer [Internet]."},{"issue":"3","key":"pone.0293833.ref061","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4149\/neo_2013_038","article-title":"Distant metastasis in triple-negative breast cancer","volume":"60","author":"LM Tseng","year":"2013","journal-title":"Neoplasma [Internet]."},{"key":"pone.0293833.ref062","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fonc.2020.00014","article-title":"A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis.","volume":"10","author":"Z Wang","year":"2020","journal-title":"Front Oncol"},{"issue":"5","key":"pone.0293833.ref063","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.prp.2014.01.008","article-title":"Prognostic factors in patients with metastatic breast cancer at the time of diagnosis","volume":"210","author":"Z Ren","year":"2014","journal-title":"Pathol Res Pract"},{"issue":"12","key":"pone.0293833.ref064","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.31557\/APJCP.2020.21.12.3587","article-title":"Different Breast Cancer Subtypes Show Different Metastatic Patterns: A Study from A Large Public Database.","volume":"21","author":"Y Guo","year":"2020","journal-title":"Asian Pac J Cancer Prev [Internet]."},{"issue":"1","key":"pone.0293833.ref065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1006285726561","article-title":"Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients","volume":"56","author":"A Insa","year":"1999","journal-title":"Breast Cancer Res Treat [Internet]."},{"issue":"6","key":"pone.0293833.ref066","first-page":"561","article-title":"[Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases].","volume":"27","author":"ZY Yuan","year":"2008","journal-title":"Ai Zheng [Internet]."},{"issue":"1","key":"pone.0293833.ref067","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-010-0998-5","article-title":"Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival","volume":"123","author":"JA Lee","year":"2010","journal-title":"Breast Cancer Res Treat [Internet]."},{"issue":"1","key":"pone.0293833.ref068","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2478\/v10019-010-0054-4","article-title":"Triple negative breast cancer\u2014Prognostic factors and survival.","volume":"45","author":"T Ovcaricek","year":"2011","journal-title":"Radiol Oncol."},{"issue":"3","key":"pone.0293833.ref069","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/prm2.12107","article-title":"Patterns of distant metastases in patients with triple-negative breast cancer\u2014A population-based study.","volume":"12","author":"Y Gao","year":"2023","journal-title":"Precision Medical Sciences."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0293833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T18:44:06Z","timestamp":1706813046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0293833"}},"subtitle":[],"editor":[{"given":"Divijendra Natha Reddy","family":"Sirigiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0293833","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}